Dendritic Cell–Based Cancer Vaccines
The Journal of Immunology2018Vol. 200(2), pp. 443–449
Citations Over TimeTop 1% of 2018 papers
Abstract
Dendritic cells (DC) are specialized immune cells that play a critical role in promoting an immune response against Ags, which can include foreign pathogenic Ags and self-tumor Ags. DC are capable of boosting a memory T cell response but most importantly they are effective initiators of naive T cell responses. Many years of studies have focused on the use of DC vaccines against cancer to initiate and shape an antitumor-specific immune response and/or boost existing spontaneous antitumor T cell responses. In this study we give a brief overview of DC biology, function, and cellular subsets, and review the current status of the field of DC as cancer vaccines.
Related Papers
- Dendritic cells-based cancer vaccine : Cancer immunotherapy with tumor/dendritic cell fusions(2012)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- → Abstract 5010: Development of a universal cancer vaccine using common cancer antigens cocktail that targets various cancer patients and overcomes the heterogeneity of individual cancer(2024)